150 related articles for article (PubMed ID: 1559298)
1. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
2. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
Ciccarelli E; Ghigo E; Miola C; Gandini G; Muller EE; Camanni F
Clin Endocrinol (Oxf); 1990 May; 32(5):583-92. PubMed ID: 2114241
[TBL] [Abstract][Full Text] [Related]
4. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
5. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
[TBL] [Abstract][Full Text] [Related]
6. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
[TBL] [Abstract][Full Text] [Related]
7. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
8. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
10. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
[TBL] [Abstract][Full Text] [Related]
11. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
[TBL] [Abstract][Full Text] [Related]
12. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas].
Sato S
Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284
[TBL] [Abstract][Full Text] [Related]
13. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
15. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
Yokoyama M
No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
[TBL] [Abstract][Full Text] [Related]
16. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
Ghigo E; Pogliano G; Campagnoli C; Bertagna A; Camanni F; Massara F
J Endocrinol Invest; 1984 Oct; 7(5):525-7. PubMed ID: 6439773
[TBL] [Abstract][Full Text] [Related]
18. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of dopaminergic regulation of prolactin in patients with functioning and nonfunctioning pituitary adenomas and craniopharyngiomas.
Martinez-Campos A; Cornejo J; Garza-Flores J; Velasco F
Fertil Steril; 1985 Oct; 44(4):471-7. PubMed ID: 4054318
[TBL] [Abstract][Full Text] [Related]
20. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]